Shinde, A.; Tang, X.; Singh, R.; Brindley, D.N.
Infliximab, a Monoclonal Antibody against TNF-α, Inhibits NF-κB Activation, Autotaxin Expression and Breast Cancer Metastasis to Lungs. Cancers 2024, 16, 52.
https://doi.org/10.3390/cancers16010052
AMA Style
Shinde A, Tang X, Singh R, Brindley DN.
Infliximab, a Monoclonal Antibody against TNF-α, Inhibits NF-κB Activation, Autotaxin Expression and Breast Cancer Metastasis to Lungs. Cancers. 2024; 16(1):52.
https://doi.org/10.3390/cancers16010052
Chicago/Turabian Style
Shinde, Anjali, Xiaoyun Tang, Rajesh Singh, and David N. Brindley.
2024. "Infliximab, a Monoclonal Antibody against TNF-α, Inhibits NF-κB Activation, Autotaxin Expression and Breast Cancer Metastasis to Lungs" Cancers 16, no. 1: 52.
https://doi.org/10.3390/cancers16010052
APA Style
Shinde, A., Tang, X., Singh, R., & Brindley, D. N.
(2024). Infliximab, a Monoclonal Antibody against TNF-α, Inhibits NF-κB Activation, Autotaxin Expression and Breast Cancer Metastasis to Lungs. Cancers, 16(1), 52.
https://doi.org/10.3390/cancers16010052